Efthymios Deliargyris serves as Executive at Cytosorbents Corp, where they oversee executive responsibilities. Since joining the company, Efthymios Deliargyris has executed 8 insider transactions totaling $30.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 8, 2025 involved receiving (via award) 70,000 shares valued at $0.
Efthymios Deliargyris currently holds 473,025 shares of Cytosorbents Corp (CTSO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Efthymios Deliargyris has been a net buyer of CTSO stock. They have purchased $30.0K and sold $0 worth of shares.
Efthymios Deliargyris's most recent insider trade was on Aug 8, 2025, when they sold 70,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 13, 2023 | CTSO | $30.0K | Purchase | 22,557 | $1.33 | Discretionary |
| Jul 7, 2023 | CTSO | $0 | Award | 55,000 | $N/A | Discretionary |
| Aug 10, 2022 | CTSO | $0 | Award | 55,000 | $N/A | Discretionary |
| Aug 10, 2022 | CTSO | $0 | Award | 52,000 | $N/A | Discretionary |
| Apr 12, 2021 | CTSO | $359.6K | Award | 40,000 | $8.99 | Discretionary |
| Apr 12, 2020 | CTSO | $0 | Award | 140,000 | $N/A | Discretionary |